These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6075134)

  • 21. [Methyl heptine carbonate skin test in lung cancer--correlation with stage and prognosis].
    Takanami I; Nakayama H; Ishihara T; Yanai N
    Gan No Rinsho; 1984 Apr; 30(4):340-3. PubMed ID: 6727035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal.
    Hu SC; Chen GS; Lu YW; Wu CS; Lan CC
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):735-40. PubMed ID: 18312322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
    J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy in metastatic and locally advanced non-small cell lung cancer.
    Spigel DR; Greco FA
    Semin Surg Oncol; 2003; 21(2):98-110. PubMed ID: 14508860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
    Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotational stress reduces the effectiveness of antitumor drugs in mice.
    Giraldi T; Perissin L; Zorzet S; Rapozzi V
    Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811
    [No Abstract]   [Full Text] [Related]  

  • 28. [The tuberculin reaction in patients with malignant tumors of lungs (preliminary report) (author's transl)].
    Krzak J
    Przegl Lek; 1978; 35(6):621-2. PubMed ID: 694056
    [No Abstract]   [Full Text] [Related]  

  • 29. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
    Maione P; Rossi A; Di Maio M; Gridelli C
    Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying an optimum treatment strategy for patients with advanced non-small cell lung cancer.
    Grossi F; Gridelli C; Aita M; De Marinis F
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):16-26. PubMed ID: 18243728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer.
    Iwanicki-Caron I; Di Fiore F; Roque I; Astruc E; Stetiu M; Duclos A; Tougeron D; Saillard S; Thureau S; Benichou J; Paillot B; Basuyau JP; Michel P
    J Clin Oncol; 2008 Aug; 26(22):3681-6. PubMed ID: 18669452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
    Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current status of cancer chemotherapy for selected human neoplasms.
    Rubin RN
    Clin Ther; 1981; 4(2):74-94. PubMed ID: 7028265
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].
    Brückl WM; Lampert S; Zirlik S; Hahn EG; Wiest GH
    Pneumologie; 2008 Jan; 62(1):23-30. PubMed ID: 17948174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of TUCAN, an inhibitor of apoptosis protein, in patients with advanced non-small cell lung cancer treated with chemotherapy.
    Checinska A; Oudejans JJ; Span SW; Rodriguez JA; Kruyt FA; Giaccone G
    Anticancer Res; 2006; 26(5B):3819-24. PubMed ID: 17094407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neoadjuvant chemoradiation in non-small cell lung cancer].
    Milleron B; Girard N; Gounant V; Mornex F
    Cancer Radiother; 2007; 11(1-2):36-40. PubMed ID: 17055314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cutaneous immunologic reactions in lung cancer patients].
    Averkieva MN; Trakhtenberg AKh
    Vopr Onkol; 1970; 16(8):20-4. PubMed ID: 5501881
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pro and con: small cell bronchial cancer - surgery or chemotherapy as the primary treatment. Arguments for primary chemotherapy].
    Seeber S
    Internist (Berl); 1981 Nov; 22(11):653-5. PubMed ID: 6273353
    [No Abstract]   [Full Text] [Related]  

  • 40. Treating invasive lung cancer.
    Boyer MW
    Am J Nurs; 1977 Dec; 77(12):1916-23. PubMed ID: 244254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.